IMNM,Immunome, Inc. | Healthcare

Healthcare

IMNM

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Immunome, Inc.IMNM

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

Market Cap

590.39M

Revenue (ttm)

9.04M

Net Income (ttm)

-292.96M

Shares Out

86.95M

EPS (ttm)

-5.00

PE Ratio

n/a

Forward PE

n/a

Dividend

n/a

Ex-Dividend Date

n/a

Volume

408,818

Open

6.14

Previous Close

6.20

Day's Range

6.11 - 6.88

52-Week Range

5.15 - 21.72

Beta

2.06

Analysts

Strong Buy

Price Target

26.00 (+282.92%)

Earnings Date

May 13, 2025

Description >

Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease.

The company's lead oncology program includes IMM-ONC-01 that targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system.

It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2 infections and COVID-19.

The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.

Latest News >

Rocket Pharmaceuticals Says FDA Seeks More Information on Kresladi

Jun 28, 2024

10:28 AM EDT, 06/28/2024 (MT Newswires) -- Rocket Pharmaceuticals ( RCKT ) said Friday that the US Food and Drug Administration has issued a Complete Response Letter following its Biologics License Application for Kresladi to treat severe leukocyte adhesion deficiency-I. The company said the FDA requested limited additional Chemistry Manufacturing and Controls information to complete its review. Rocket said it...

Unpacking the Latest Options Trading Trends in Qualcomm

Jun 28, 2024

High-rolling investors have positioned themselves bullish on Qualcomm ( QCOM ) , and it's important for retail traders to take note. This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in QCOM often signals that someone has privileged information. Today, Benzinga's options...

European Commission To Decide On Hewlett Packard Enterprise's $14B Juniper Networks Acquisition By August 1: Details

Jun 28, 2024

The European Commission regulators are reportedly set to decide by August 1 on whether to approve Hewlett Packard Enterprise Company’s $14 billion acquisition of Juniper Networks, Inc. ( JNPR ) . Announced in January, the deal aims to enhance Hewlett Packard Enterprise’s artificial intelligence offerings and expand its networking business, reflecting the strategic focus on AI as a key growth...

US inflation ebbs in May as goods prices fall

Jun 28, 2024

* PCE price index flat in May; up 2.6% on year-on-year basis * Core PCE edges up 0.1%; rises 2.6% on year-on-year basis * Consumer spending gains 0.2%; personal income up 0.5% By Lucia Mutikani WASHINGTON, June 28 (Reuters) - U.S. monthly inflation was unchanged in May as a modest increase in the cost of services was offset by the...